Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice Sanofi Ongoing Lantus®/Apidra® 4 LANTUR06314 Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women Sanofi Ongoing LACTOSERUM LACTIC ACID 4 LACACL06308 Dr. Erfan & Bagedo General Hospital (Jeddah)
multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D Sanofi Ongoing N/A 4 OBS13593 Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah)
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) GSK Ongoing Lapatinib / Capecitabine 4 113780 King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)
An Observational, Cross-sectional Study on the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in adult Population within the MENA Region. GSK Ongoing N/A 4 Version 2.1 - 30/08/2009 Prince Sultan Military Medical City (Riyadh)
Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East : AFME Cardiovascular Epidemiology (ACE) Study. Pfizer Ongoing N/A 4 A2581186 Dallah Hospital (Riyadh), Al Mana General Hospital (Khobar), University District Hospital (Jeddah), Al Shifa Medical Hospital (Makkah)
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 Roche Ongoing Pegasys 3 ML22728 King Abdulaziz Medical City NG (Riyadh)
Changing Diabetes® World Tour Novonordisk Ongoing N/A 4 version 6 - October 2010 King Abdulaziz University Hospital (Jeddah)
An observational study to evaluate caregiver's preference and treatment outcome in patient with alzheimer's disease treated with oral or tramsdermal monotheraby - Real-World Evaluation of compliance and preference in the treatment of Alzheimer's disease(RECAP). Novartis Ongoing Rivastigmine 4 CENA713D-MAX-SA-01 Dr. Soliman Fakeeh Hospital (Jeddah)
DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 AstraZeneca Ongoing N/A 4 D1690R0000 King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah)
View 631 - 640 From 756